These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22175896)

  • 1. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
    Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
    Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role and prognostic significance of CD157 in ovarian carcinoma.
    Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
    J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.
    Au CW; Siu MK; Liao X; Wong ES; Ngan HY; Tam KF; Chan DC; Chan QK; Cheung AN
    Cancer Lett; 2009 Aug; 281(2):151-61. PubMed ID: 19307055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological role and prognostic significance of NAC1 in ovarian cancer.
    Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
    Zhao Y; Zong ZH; Xu HM
    Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
    Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer.
    Li YL; Ye F; Cheng XD; Hu Y; Zhou CY; Lü WG; Xie X
    Eur J Cancer; 2010 Jul; 46(11):2104-18. PubMed ID: 20547056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
    Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
    Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
    Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
    Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma.
    Lassus H; Staff S; Leminen A; Isola J; Butzow R
    Gynecol Oncol; 2011 Jan; 120(1):11-7. PubMed ID: 20937525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elmo1 helps dock180 to regulate Rac1 activity and cell migration of ovarian cancer.
    Wang J; Dai JM; Che YL; Gao YM; Peng HJ; Liu B; Wang H; Linghu H
    Int J Gynecol Cancer; 2014 Jun; 24(5):844-50. PubMed ID: 24819662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
    Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.
    Chen YJ; Yuan CC; Chow KC; Wang PH; Lai CR; Yen MS; Wang LS
    Gynecol Oncol; 2005 Apr; 97(1):110-7. PubMed ID: 15790446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.